目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Product
1.2.3. Indication
1.2.4. End Use
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Neurointerventional Devices Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Incidence of Neurovascular Disorders
3.2.1.2. Growing Preference for Minimally Invasive Procedures
3.2.1.3. Regulatory Approvals and Reimbursement Policies
3.2.2. Market Restraint Analysis
3.2.2.1. High procedural and device costs
3.2.3. Market Opportunities Analysis
3.2.3.1. Rising prevalence of stroke and cerebrovascular disorders
3.2.3.2. Integration of AI and robotics
3.2.4. Market Challenges Analysis
3.2.4.1. Complexity of neurovascular anatomy
3.2.4.2. Device-related risks and failures
3.3. Neurointerventional Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape

Chapter 4. Neurointerventional Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Neurointerventional Devices Market: Product Movement Analysis & Market Share, 2024 & 2030
4.3. Diagnostic Devices
4.3.1. Diagnostic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.1.1. Catheters
4.3.1.1.1. Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.1.1.1.1. Distal Access Catheters
4.3.1.1.1.1.1. Distal Access Catheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.1.1.1.2. Microcatheters
4.3.1.1.1.1.2. Microcatheters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.1.1.1.3. Others
4.3.1.1.1.1.3. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.1.2. Guidewires
4.3.1.1.2. Guidewires Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.1.3. Imaging Systems
4.3.1.3.1. Imaging Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. Therapeutic Devices
4.4.1. Therapeutic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.1. Embolic Materials
4.4.1.1.1. Embolic Materials Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.1.1.1. Embolic Coils
4.4.1.1.1.1.1. Embolic Coils Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.1.1.2. Embolic Agents
4.2.1.1.1.2.1. Embolic Agents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.2. Neurovascular Stents
4.4.1.2.1. Neurovascular Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.2.1.1. Self-Expanding Stents
4.4.1.2.1.1.1. Self-Expanding Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.2.1.2. Balloon-Expandable Stents
4.4.1.2.1.2.1. Balloon-Expandable Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.2.1.3. Flow Diverter Stents
4.4.1.2.1.3.1. Flow Diverter Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.2.1.4. Coil-Assist Stents
4.4.1.2.1.4.1. Coil-Assist Stents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.3. Neurothrombectomy Devices
4.4.1.3.1. Neurothrombectomy Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.4. Intrasaccular Devices
4.4.1.4.1. Intrasaccular Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.5. Embolic Protection Devices
4.4.1.5.1. Embolic Protection Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.1.6. Others
4.4.1.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Neurointerventional Devices Market: Indication Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Neurointerventional Devices Market: Indication Movement Analysis & Market Share, 2024 & 2030
5.3. Acute Ischemic Stroke (AIS)
5.3.1. Acute Ischemic Stroke (AIS) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. Intracranial Aneurysm
5.4.1. Intracranial Aneurysm Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Cerebral Arterial Stenosis
5.5.1. Cerebral Arterial Stenosis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Arteriovenous Malformation (AVM)
5.6.1. Arteriovenous Malformation (AVM) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Spinal Vascular Malformations
5.7.1. Spinal Vascular Malformations Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Neurointerventional Devices Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Neurointerventional Devices Market: End Use Movement Analysis & Market Share, 2024 & 2030
6.3. Hospitals
6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Specialty Clinics
6.4.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Ambulatory Surgery Centers
6.5.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Others
6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Neurointerventional Devices Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Neurointerventional Devices Market: Regional Movement Analysis & Market Share, 2024 & 2030
7.3. North America
7.3.1. North America Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Scenario
7.3.2.4. Reimbursement Scenario
7.3.2.5. U.S. Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Scenario
7.3.3.4. Reimbursement Scenario
7.3.3.5. Canada Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Scenario
7.3.4.4. Reimbursement Scenario
7.3.4.5. Mexico Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4. Europe
7.4.1. Europe Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.2. UK
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Regulatory Scenario
7.4.2.4. Reimbursement Scenario
7.4.2.5. UK Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.3. Germany
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Regulatory Scenario
7.4.3.4. Reimbursement Scenario
7.4.3.5. Germany Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.4. France
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Regulatory Scenario
7.4.4.4. Reimbursement Scenario
7.4.4.5. France Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.5. Italy
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Regulatory Scenario
7.4.5.4. Reimbursement Scenario
7.4.5.5. Italy Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.6. Spain
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Regulatory Scenario
7.4.6.4. Reimbursement Scenario
7.4.6.5. Spain Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.7. Denmark
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Regulatory Scenario
7.4.7.4. Reimbursement Scenario
7.4.7.5. Denmark Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.8. Sweden
7.4.8.1. Key Country Dynamics
7.4.8.2. Competitive Scenario
7.4.8.3. Regulatory Scenario
7.4.8.4. Reimbursement Scenario
7.4.8.5. Sweden Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.9. Norway
7.4.9.1. Key Country Dynamics
7.4.9.2. Competitive Scenario
7.4.9.3. Regulatory Scenario
7.4.9.4. Reimbursement Scenario
7.4.9.5. Norway Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Asia Pacific
7.5.1. Asia Pacific Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.2. Japan
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Scenario
7.5.2.4. Reimbursement Scenario
7.5.2.5. Japan Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.3. China
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Scenario
7.5.3.4. Reimbursement Scenario
7.5.3.5. China Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.4. India
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Scenario
7.5.4.4. Reimbursement Scenario
7.5.4.5. India Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.5. South Korea
7.5.5.1. Key Country Dynamics
7.5.5.2. Competitive Scenario
7.5.5.3. Regulatory Scenario
7.5.5.4. Reimbursement Scenario
7.5.5.5. South Korea Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.6. Australia
7.5.6.1. Key Country Dynamics
7.5.6.2. Competitive Scenario
7.5.6.3. Regulatory Scenario
7.5.6.4. Reimbursement Scenario
7.5.6.5. Australia Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.7. Thailand
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Scenario
7.5.7.4. Reimbursement Scenario
7.5.7.5. Thailand Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Latin America
7.6.1. Latin America Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.2. Brazil
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Scenario
7.6.2.4. Reimbursement Scenario
7.6.2.5. Brazil Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.3. Argentina
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Scenario
7.6.3.4. Reimbursement Scenario
7.6.3.5. Argentina Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Middle East & Africa
7.7.1. Middle East & Africa Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.2. South Africa
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Scenario
7.7.2.4. Reimbursement Scenario
7.7.2.5. South Africa Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.3. Saudi Arabia
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Scenario
7.7.3.4. Reimbursement Scenario
7.7.3.5. Saudi Arabia Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.4. UAE
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Scenario
7.7.4.4. Reimbursement Scenario
7.7.4.5. UAE Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Scenario
7.7.5.4. Reimbursement Scenario
7.7.5.5. Kuwait Neurointerventional Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Terumo Neuro
8.2.1.1. Company Overview
8.2.1.2. Financial Performance
8.2.1.3. Technology Benchmarking
8.2.1.4. Strategic Initiatives
8.2.2. NeuroSafe Medical Co., Ltd
8.2.2.1. Company Overview
8.2.2.2. Financial Performance
8.2.2.3. Technology Benchmarking
8.2.2.4. Strategic Initiatives
8.2.3. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
8.2.3.1. Company Overview
8.2.3.2. Financial Performance
8.2.3.3. Technology Benchmarking
8.2.3.4. Strategic Initiatives
8.2.4. Brain Navi Biotechnology Co., Ltd.
8.2.4.1. Company Overview
8.2.4.2. Financial Performance
8.2.4.3. Technology Benchmarking
8.2.4.4. Strategic Initiatives
8.2.5. Medtronic
8.2.5.1. Company Overview
8.2.5.2. Financial Performance
8.2.5.3. Technology Benchmarking
8.2.5.4. Strategic Initiatives
8.2.6. Stryker
8.2.6.1. Company Overview
8.2.6.2. Financial Performance
8.2.6.3. Technology Benchmarking
8.2.6.4. Strategic Initiatives
8.2.7. CERENOVUS (Johnson & Johnson)
8.2.7.1. Company Overview
8.2.7.2. Financial Performance
8.2.7.3. Technology Benchmarking
8.2.7.4. Strategic Initiatives
8.2.8. Integra LifeSciences Corporation
8.2.8.1. Company Overview
8.2.8.2. Financial Performance
8.2.8.3. Technology Benchmarking
8.2.8.4. Strategic Initiatives
8.2.9. Penumbra Inc
8.2.9.1. Company Overview
8.2.9.2. Financial Performance
8.2.9.3. Technology Benchmarking
8.2.9.4. Strategic Initiatives
8.2.10. Balt SAS
8.2.10.1. Company Overview
8.2.10.2. Financial Performance
8.2.10.3. Technology Benchmarking
8.2.10.4. Strategic Initiatives
8.2.11. B. Braun SE
8.2.11.1. Company Overview
8.2.11.2. Financial Performance
8.2.11.3. Technology Benchmarking
8.2.11.4. Strategic Initiatives
8.2.12. Phenox GmbH
8.2.12.1. Company Overview
8.2.12.2. Financial Performance
8.2.12.3. Technology Benchmarking
8.2.12.4. Strategic Initiatives
8.2.13. Shanghai MicroPort Medical (Group) Co. Ltd.
8.2.13.1. Company Overview
8.2.13.2. Financial Performance
8.2.13.3. Technology Benchmarking
8.2.13.4. Strategic Initiatives
8.2.14. Boston Scientific Corporation
8.2.14.1. Company Overview
8.2.14.2. Financial Performance
8.2.14.3. Technology Benchmarking
8.2.14.4. Strategic Initiatives
8.2.15. Meril
8.2.15.1. Company Overview
8.2.15.2. Financial Performance
8.2.15.3. Technology Benchmarking
8.2.15.4. Strategic Initiatives
8.2.16. Gem srl
8.2.16.1. Company Overview
8.2.16.2. Financial Performance
8.2.16.3. Technology Benchmarking
8.2.16.4. Strategic Initiatives
8.2.17. Sirtex (BlackSwan Vascular, Inc.)
8.2.17.1. Company Overview
8.2.17.2. Financial Performance
8.2.17.3. Technology Benchmarking
8.2.17.4. Strategic Initiatives
8.2.18. INVAMED
8.2.18.1. Company Overview
8.2.18.2. Financial Performance
8.2.18.3. Technology Benchmarking
8.2.18.4. Strategic Initiatives
8.2.19. Merit Medical Systems
8.2.19.1. Company Overview
8.2.19.2. Financial Performance
8.2.19.3. Technology Benchmarking
8.2.19.4. Strategic Initiatives
8.2.20. Abbott
8.2.20.1. Company Overview
8.2.20.2. Financial Performance
8.2.20.3. Technology Benchmarking
8.2.20.4. Strategic Initiatives
8.2.21. Acandis GmbH
8.2.21.1. Company Overview
8.2.21.2. Financial Performance
8.2.21.3. Technology Benchmarking
8.2.21.4. Strategic Initiatives
8.2.22. Cook Medical
8.2.22.1. Company Overview
8.2.22.2. Financial Performance
8.2.22.3. Technology Benchmarking
8.2.22.4. Strategic Initiatives
8.2.23. Imperative Care, Inc.
8.2.23.1. Company Overview
8.2.23.2. Financial Performance
8.2.23.3. Technology Benchmarking
8.2.23.4. Strategic Initiatives
8.2.24. Rapid Medical
8.2.24.1. Company Overview
8.2.24.2. Financial Performance
8.2.24.3. Technology Benchmarking
8.2.24.4. Strategic Initiatives
8.2.25. Koninklijke Philips N.V.
8.2.25.1. Company Overview
8.2.25.2. Financial Performance
8.2.25.3. Technology Benchmarking
8.2.25.4. Strategic Initiatives
8.2.26. KANEKA CORPORATION
8.2.26.1. Company Overview
8.2.26.2. Financial Performance
8.2.26.3. Technology Benchmarking
8.2.26.4. Strategic Initiatives
8.3. Heat Map Analysis/ Company Market Position Analysis
8.4. Company Market Share Analysis, 2024

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America Neurointerventional devices market, by country, 2021 - 2033 (USD Million)
Table 4 North America Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 5 North America Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 6 North America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 7 U.S. Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 8 U.S. Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 9 U.S. North America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 10 Canada Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 11 Canada Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 12 Canada North America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 13 Mexico Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 14 Mexico Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 15 Mexico North America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 16 Europe Neurointerventional devices market, by country, 2021 - 2033 (USD Million)
Table 17 Europe Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 18 Europe Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 19 Europe North America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 20 UK Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 21 UK Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 22 UK Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 23 Germany Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 24 Germany Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 25 Germany Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 26 France Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 27 France Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 28 France Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 29 Italy Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 30 Italy Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 31 Italy Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 32 Spain Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 33 Spain Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 34 Spain Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 35 Norway Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 36 Norway Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 37 Norway Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 38 Sweden Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 39 Sweden Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 40 Sweden Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 41 Denmark Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 42 Denmark Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 43 Denmark Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 44 Asia Pacific Neurointerventional devices market, by country, 2021 - 2033 (USD Million)
Table 45 Asia Pacific Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 46 Asia Pacific Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 47 Asia Pacific Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 48 China Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 49 China Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 50 China Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 51 Japan Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 52 Japan Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 53 Japan Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 54 India Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 55 India Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 56 India Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 57 Australia Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 58 Australia Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 59 Australia Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 60 South Korea Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 61 South Korea Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 62 South Korea Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 63 Thailand Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 64 Thailand Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 65 Thailand Korea Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 66 Latin America Neurointerventional devices market, by country, 2021 - 2033 (USD Million)
Table 67 Latin America Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 68 Latin America Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 69 Latin America Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 70 Brazil Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 71 Brazil Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 72 Brazil Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 73 Argentina Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 74 Argentina Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 75 Argentina Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 76 Middle East & Africa Neurointerventional devices market, by country, 2021 - 2033 (USD Million)
Table 77 Middle East & Africa Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 78 Middle East & Africa Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 79 Middle East & Africa Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 80 South Africa Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 81 South Africa Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 82 South Africa Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 83 Saudi Arabia Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 84 Saudi Arabia Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 85 Saudi Arabia Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 86 UAE Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 87 UAE Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 88 UAE Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)
Table 89 Kuwait Neurointerventional devices market, by product, 2021 - 2033 (USD Million)
Table 90 Kuwait Neurointerventional devices market, by indication, 2021 - 2033 (USD Million)
Table 91 Kuwait Neurointerventional devices market, by end use, 2021 - 2033 (USD Million)

List of Figures
Fig. 1 Information procurement
Fig. 2 Neurointerventional devices market segmentation
Fig. 3 Market research process
Fig. 4 Information procurement process
Fig. 5 Primary research pattern
Fig. 6 Neurointerventional devices market snapshot, 2024 (USD Million)
Fig. 7 Segment snapshot, USD Million
Fig. 8 Competitive landscape snapshot
Fig. 9 Penetration & growth prospect mapping, by Technology
Fig. 10 Market driver analysis (Current & future impact)
Fig. 11 Market restraint analysis (Current & future impact)
Fig. 12 Market opportunity analysis (Current & future impact)
Fig. 13 Primary market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 14 Diagnostic devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 15 Catheters market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 16 Guidewires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 17 Imaging systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 18 Therapeutic devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 19 Embolic materials market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 20 Neurovascular stents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 21 Neurothrombectomy devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 Intrasaccular devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 23 Embolic protection devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 25 Acute ischemic stroke (AIS) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 26 Intracranial aneurysm market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Cerebral arterial stenosis market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Arteriovenous malformation (AVM) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Spinal vascular malformations market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 Specialty clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 32 Ambulatory surgery centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 33 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Neurointerventional devices market: Regional key takeaways (USD Million)
Fig. 35 Neurointerventional devices market: Regional outlook, 2021 & 2030, USD Million
Fig. 36 North America Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 U.S. Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 38 Canada Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 Mexico Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 40 Europe Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 UK Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 42 Germany Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 France Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 44 Spain Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 45 Italy Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 46 Sweden Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 47 Norway Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 48 Denmark Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 49 Asia Pacific Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 50 China Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 51 Japan Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 52 India Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 53 South Korea Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 54 Australia Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 55 Thailand Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 56 Latin America Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 57 Brazil Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 58 Argentina Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 59 Middle East and Africa Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 60 South Africa Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 61 Saudi Arabia Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 62 UAE Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 63 Kuwait Neurointerventional devices market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 64 List of key emerging companies
Fig. 65 Company market share analysis, 2024
Fig. 66 Market differentiators
Fig. 67 Competitive dashboard analysis
Fig. 68 Regional network map